WASTE MANAGEMENT OR REVERSE DISTRIBUTION OF MEDICINES IN UKRAINE

Authors

DOI:

https://doi.org/10.11603/2312-0967.2022.4.13747

Keywords:

pharmaceutical industry, medicines, medical devices, reverse distribution, logistics and waste management

Abstract

The aim of the work. The purpose of the study was a comparative analysis of two legislative acts, which will allow to establish the logistics of the reverse distribution of medicines and medical devices, which at the end of their life cycle will acquire the status of waste.

Materials and Methods. The materials were the structure and content of the provisions of two normative legal acts that had the status of "active" – the Law of Ukraine "On Waste" and the one "coming into force" – the Law of Ukraine "On Waste Management". The methods of analysis, grouping and modeling were used.

Results  and  Discussion. The list of licensees who have permission to conduct economic activities with various types of medical (pharmaceutical) waste has been studied. An analysis of the similarities and differences of two legislative acts – the current one and the one coming into force on waste management in Ukraine – has been carried out. Approaches are proposed and threats are foreseen, which must be taken into account when developing medical (pharmaceutical) sectoral normative legal acts.

Conclusion. A comparative analysis of the two Laws of Ukraine made it possible to establish that the new legislation is more progressive and regulates significantly more economic functions. However, the state and the legislator shift more responsibility to the waste producer and local (regional) self-government bodies. It is predicted that the legislator will introduce stricter liability for improper waste management. It is recommended to take into account the circumstances, namely the Covid-19 pandemic and the war with the Russian Federation, which led to the accumulation of large volumes of used medicines and medical devices that were imported into the territory of Ukraine, when developing sectoral medical (pharmaceutical) normative legal acts.

Author Biographies

A. M. Krychkovska, Lviv Polytechnic National University

PhD (Pharmacy), Associate Professor, Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

N. I. Ilkiv, Lviv Polytechnic National University

discoverer, Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

O. I. Khomenko, Lviv Medical Institute

PhD (Chemistry), Assistant, Department of Physics and Chemistry

V. I. Lubenets, Lviv Polytechnic National University

PhD (Chemistry), Professor,  Head of Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

References

Stych M, Pawlica B. Reverse drug distribution in Poland. Curr. Issues Pharm. Med. Sci., 2021;34(3): 149-153. Available from: https://doi.org/10.2478/cipms-2021-0028 DOI: https://doi.org/10.2478/cipms-2021-0028

Khan F, Ali Y. Implementation of the circular supply chain management in the pharmaceutical industry. Environ. Dev. Sustain., 2022;24(12): 13705-31. Available from: https://doi.org/10.1007/s10668-021-02007-6 DOI: https://doi.org/10.1007/s10668-021-02007-6

Al-Awamleh H, Alhalalmeh M, Alatyat Z, Saraireh S, Akour I, Alneimat S, & Al-Hawary S, et al. The effect of green supply chain on sustainability: Evidence from the pharmaceutical industry. Uncertain Supply Chain Manag., 2022;10(4): 1261-70. Available from: http://dx.doi.org/10.5267/j.uscm.2022.8.002 DOI: https://doi.org/10.5267/j.uscm.2022.8.002

Ranjbar Z, Mirzazadeh A. The forward and reverse pharmaceutical supply chain network design considering tainted product delivery. Int. J. Logist. Syst. Manag., 2019,33(2): 205-20. Available from: https://doi.org/10.1504/IJLSM.2019.100110 DOI: https://doi.org/10.1504/IJLSM.2019.100110

Lima PAB, Delgado FCM, dos Santos TL, Florentino AP. Medications reverse logistics: A systematic literature review and a method for improving the Brazilian case. Cleaner Logist. Supply Chain. 2022; 100024. Available from: https://doi.org/10.1016/j.clscn.2021.100024 DOI: https://doi.org/10.1016/j.clscn.2021.100024

Luna RA, Emerenciano Viana FL. The role of the national solid waste policy in reverse logistics in pharmaceutical companies. RGSA – Revista de Gestão Social e Ambiental, 2019, 13 (1): 40-56. Available from: https://doi.org/10.24857/rgsa.v13i1.1640 DOI: https://doi.org/10.24857/rgsa.v13i1.1640

Ismail LB, Alawamleh M, Aladwan K, Alragheb AA. The relationship between green SCM practices and organisational performance: Evidence from Jordanian pharmaceutical manufacturers. Int J Logist Syst Manag. 2019;34(2): 172-92. Available from: https://doi.org/10.1504/IJLSM.2019.102209 DOI: https://doi.org/10.1504/IJLSM.2019.102209

Lahjouji M, Bassou AA, Alami JE, Hlya M, Lahjouji O. A new mathematic model for humanitarian pharmaceutical supply chain to reduce obsolesence cost. J Theor Appl Inf Technol., 2022;100(9): 3107-3119. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131747888&partnerID=40&md5=612027cbcbaf6a9d4c56684908716777

Makaleng MS, Lambert KR. Evaluation of Reverse Logistics in Challenges within the Manufacturing Pharmaceutical Companies. Emerg. Sci J 2021;2021:5(4): 486-496. DOI: 10.28991/esj-2021-01291 DOI: https://doi.org/10.28991/esj-2021-01291

Ribeiro DP, de Oliveira UR, da Silva César A, Aprigliano Fernandes V. Evaluation of medicine reverse logistics practices in hospitals. Sustainability. 2021;13(6): 3496. Available from: https://doi.org/10.3390/su13063496 DOI: https://doi.org/10.3390/su13063496

Manzolillo B. Reverse logistics: A solution for medicines disposition at home | [Logística inversa: Una solución a la disposición de medicamentos en el hogar]. Gac Méd Caracas. 2021;129(1): 13-21. DOI: 10.47307/GMC.2021.129.1.3 DOI: https://doi.org/10.47307/GMC.2021.129.1.3

[On waste: Law of Ukraine], adopted on March 5, 1998, revised on October 16, 2020, No. 187/98-VR. Official bulletin of Ukraine. 1998, 13: 23, act code 5121/1998.

[On waste management: Law of Ukraine], adopted on June 20, 2022, enters into force on July 9, 2023b No. 2320-IX. Official bulletin of Ukraine. 2022, 56: 21, Article 3270, act code 112458/2022.

[License register (hazardous waste management)]. URL: https://mepr.gov.ua/content/perelik-licenziativ-na-provadzhennya-gospodarskoi-diyalnosti-z-povodzhennya-z-nebezpechnimi-vidhodami.html

Abahussain, EA, Ball DE. Disposal of unwanted medicines from households in Kuwait. Pharm World Sci. 2007, 29: 368–373. Available from: https://doi.org/10.1007/s11096-006-9082-y DOI: https://doi.org/10.1007/s11096-006-9082-y

SanJuan-Reyes N, Gómez-Oliván LM, Islas-Flores H, Castro-Pastrana LI. Control of environmental pollution caused by pharmaceuticals. In: Ecopharmacovigilance. The Handbook of Environmental Chemistry; Switzerland: Springer, Cham; 2017;66. P. 255–264. Available from: https://doi.org/10.1007/698_2017_152 DOI: https://doi.org/10.1007/698_2017_152

Kohl S. EAHP opinion on pharmaceuticals in the environment. Eur J Hosp Pharm. 2019;26(4): 235-6. Available from: https://ejhp.bmj.com/content/26/4/237 DOI: https://doi.org/10.1136/ejhpharm-2019-002004

Published

2022-12-30

How to Cite

Krychkovska, A. M., Ilkiv, N. I., Khomenko, O. I., & Lubenets, V. I. (2022). WASTE MANAGEMENT OR REVERSE DISTRIBUTION OF MEDICINES IN UKRAINE. Pharmaceutical Review Farmacevtičnij časopis, (4), 48–57. https://doi.org/10.11603/2312-0967.2022.4.13747

Issue

Section

Pharmaceutical legislation